This growth has largely been driven by the commercial successes of GLP-1R agonists, such as Novo Nordisk's semaglutide (Wegovy) and Eli Lilly's tirzepatide (Zepbound)
Below are the protocols I commonly prescribe in my Stamford practice
Retatrutide may produce gastrointestinal symptoms similar to other GLP-1based therapies
10.3390/molecules28207177 10 AzediF.TavakolS.KetabforoushA.KhazaeiG.BakhtazadA.MousavizadehK.et al (2022)
FDA's April 30, 2026 Proposal On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List, finding no clinical need for outsourcing facilities to compound these drugs from bulk drug substances when FDA-approved versions are available
Ongoing research continues to examine its signaling activity, biological distribution, and regulatory roles within tissue remodeling systems